BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9065378)

  • 1. Postmenopausal estrogen use among African American and white patients at an urban clinic.
    Jahnige K; Fiebach N
    J Womens Health; 1997 Feb; 6(1):93-101. PubMed ID: 9065378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen replacement therapy is underutilized among postmenopausal women at high risk for coronary heart disease.
    Massey CV; Hupp CH; Kreisberg M; Alpert MA; Hoff C
    Am J Med Sci; 2000 Aug; 320(2):124-7. PubMed ID: 10981488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen replacement therapy use in minority postmenopausal women.
    Ganesan K; Teklehaimanot S; Norris K
    Ethn Dis; 2000; 10(2):257-61. PubMed ID: 10892833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do older women use estrogen replacement? Data from the Duke Established Populations for Epidemiologic Studies of the Elderly (EPESE).
    Handa VL; Landerman R; Hanlon JT; Harris T; Cohen HJ
    J Am Geriatr Soc; 1996 Jan; 44(1):1-6. PubMed ID: 8537578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The perceptions of menopause of African-American and white women and affect on willingness to participate in a HRT clinical trial.
    Strickland OL; Dunbar SB
    J Natl Black Nurses Assoc; 2000 Jan; 11(1):43-50. PubMed ID: 11854952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian aging and hormone replacement therapy. Hormonal levels, symptoms, and attitudes of African-American and white women.
    Pham KT; Grisso JA; Freeman EW
    J Gen Intern Med; 1997 Apr; 12(4):230-6. PubMed ID: 9127227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparities in women's referral to and enrollment in outpatient cardiac rehabilitation.
    Allen JK; Scott LB; Stewart KJ; Young DR
    J Gen Intern Med; 2004 Jul; 19(7):747-53. PubMed ID: 15209588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous estrogen as mediator of racial differences in bioactive insulin-like growth factor-I levels among postmenopausal women.
    Jung SY; Vitolins MZ; Paskett ED; Chang S
    J Gerontol A Biol Sci Med Sci; 2015 Apr; 70(4):495-502. PubMed ID: 25238773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethnic differences in hormone replacement prescribing patterns.
    Brown AF; Pérez-Stable EJ; Whitaker EE; Posner SF; Alexander M; Gathe J; Washington AE
    J Gen Intern Med; 1999 Nov; 14(11):663-9. PubMed ID: 10571714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group.
    Schrott HG; Bittner V; Vittinghoff E; Herrington DM; Hulley S
    JAMA; 1997 Apr 23-30; 277(16):1281-6. PubMed ID: 9109465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy for African American women: missed opportunities for effective intervention.
    Nicholson WK; Brown AF; Gathe J; Grumbach K; Washington AE; Pérez-Stable EJ
    Menopause; 1999; 6(2):147-55. PubMed ID: 10374222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health care disparities in postmenopausal women referred for DXA screening.
    Hamrick I; Steinweg KK; Cummings DM; Whetstone LM
    Fam Med; 2006 Apr; 38(4):265-9. PubMed ID: 16586173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of postmenopausal hormone replacement therapy by African American women. The importance of physician discussion.
    McNagny SE; Jacobson TA
    Arch Intern Med; 1997 Jun; 157(12):1337-42. PubMed ID: 9201008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen profiles in postmenopausal African-American women in a wheat bran fiber intervention study.
    Stark AH; Switzer BR; Atwood JR; Travis RG; Smith JL; Ullrich F; Ritenbaugh C; Hatch J; Wu X
    Nutr Cancer; 1998; 31(2):138-42. PubMed ID: 9770726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence with estrogen therapy in a postmenopausal Medicaid population.
    Kotzan JA; Martin BC; Wade WE
    Pharmacotherapy; 1999 Mar; 19(3):363-9. PubMed ID: 10221376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethnicity and vasomotor symptoms in postmenopausal women.
    Appling S; Paez K; Allen J
    J Womens Health (Larchmt); 2007 Oct; 16(8):1130-8. PubMed ID: 17937565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. African American race but not genome-wide ancestry is negatively associated with atrial fibrillation among postmenopausal women in the Women's Health Initiative.
    Perez MV; Hoffmann TJ; Tang H; Thornton T; Stefanick ML; Larson JC; Kooperberg C; Reiner AP; Caan B; Iribarren C; Risch N
    Am Heart J; 2013 Sep; 166(3):566-72. PubMed ID: 24016508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forty-year trends in menopausal hormone therapy use and breast cancer incidence among postmenopausal black and white women.
    Chlebowski RT; Aragaki AK; Anderson GL; Prentice RL
    Cancer; 2020 Jul; 126(13):2956-2964. PubMed ID: 32212335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlates of postmenopausal female hormone use among black women in the United States.
    Rosenberg L; Palmer JR; Rao RS; Adams-Campbell LL
    Obstet Gynecol; 1998 Mar; 91(3):454-8. PubMed ID: 9491877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparities in osteoporosis screening between at-risk African-American and white women.
    Miller RG; Ashar BH; Cohen J; Camp M; Coombs C; Johnson E; Schneyer CR
    J Gen Intern Med; 2005 Sep; 20(9):847-51. PubMed ID: 16117754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.